Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
|
+$30.5M |
| 2 |
AGN
Allergan plc
AGN
|
+$26.9M |
| 3 |
IPHI
INPHI CORPORATION
IPHI
|
+$23.4M |
| 4 |
Bilibili
BILI
|
+$21.7M |
| 5 |
Gaotu Techedu
GOTU
|
+$16.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vistra
VST
|
+$89.7M |
| 2 |
Dominion Energy
D
|
+$69.9M |
| 3 |
Cheniere Energy
LNG
|
+$63.1M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$62.8M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$53.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.3% |
| 2 | Financials | 15.11% |
| 3 | Consumer Discretionary | 13.23% |
| 4 | Healthcare | 12.79% |
| 5 | Communication Services | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Steris
STE
$23.2B
| $911K | 0.06% |
6,511
+4,511
| +226% | +$675K |
|
402
Sempra
SRE
$54.2B
| $907K | 0.06% |
16,054
-946
| -6% | -$67.1K |
|
|
MAXR
403
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $902K | 0.06% |
+84,500
| New | +$1.32M |
|
404
UGI
UGI
$8.06B
| $900K | 0.06% |
33,744
-3,808
| -10% | -$144K |
|
405
Marriott International
MAR
$92.9B
| $896K | 0.06% |
+11,976
| New | +$1.49M |
|
406
Hancock Whitney
HWC
$6.05B
| $888K | 0.06% |
45,501
+4,627
| +11% | +$160K |
|
407
AGNC Investment
AGNC
$12.9B
| $884K | 0.06% |
83,600
-5,710
| -6% | -$95.3K |
|
408
SBA Communications
SBAC
$19.4B
| $883K | 0.06% |
3,271
-7,212
| -69% | -$1.9M |
|
|
IBTX
409
DELISTED
Independent Bank Group, Inc.
IBTX
| $883K | 0.06% |
+37,291
| New | +$1.71M |
|
410
Qualcomm
QCOM
$169B
| $881K | 0.06% |
13,023
-57,143
| -81% | -$4.68M |
|
411
Blackbaud
BLKB
$2.16B
| $880K | 0.06% |
15,844
+12,637
| +394% | +$894K |
|
412
Performance Food Group
PFGC
$16.5B
| $875K | 0.06% |
35,400
-82,348
| -70% | -$3.54M |
|
413
Pediatrix Medical
MD
$2.16B
| $872K | 0.06% |
74,923
+11,457
| +18% | +$236K |
|
414
Bristol-Myers Squibb
BMY
$137B
| $871K | 0.05% |
15,631
-41,569
| -73% | -$2.54M |
|
415
Vertex Pharmaceuticals
VRTX
$139B
| $869K | 0.05% |
3,650
-4,572
| -56% | -$1.05M |
|
416
Zoetis
ZTS
$32.1B
| $864K | 0.05% |
7,341
-5,819
| -44% | -$766K |
|
417
AutoZone
AZO
$48.3B
| $855K | 0.05% |
1,011
-15,199
| -94% | -$15.8M |
|
418
Revvity
RVTY
$13.9B
| $853K | 0.05% |
+11,331
| New | +$1.01M |
|
419
Skywest
SKYW
$3.93B
| $852K | 0.05% |
32,521
+11,182
| +52% | +$546K |
|
420
Campbell Soup
CPB
$7.14B
| $850K | 0.05% |
18,409
+3,727
| +25% | +$179K |
|
421
NetEase
NTES
$82.1B
| $834K | 0.05% |
+13,000
| New | +$855K |
|
422
Enbridge
ENB
$110B
| $833K | 0.05% |
+28,598
| New | +$1.06M |
|
423
Nokia
NOK
$57B
| $827K | 0.05% |
+266,700
| New | +$991K |
|
424
Vertiv
VRT
$101B
| $827K | 0.05% |
+95,600
| New | +$1.06M |
|
425
Welltower
WELL
$172B
| $826K | 0.05% |
+18,042
| New | +$1.33M |
|
Similar funds
Steve Schonfeld's Q1 2020 Portfolio in Review
As of Q1 2020, Steve Schonfeld held 1,717 positions worth $1.59B, down 61% from $4.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Steve Schonfeld withdrew a net $1.91B in Q1 2020, closing 624 positions and reducing 338 holdings. Its most notable exit was Vistra, an estimated $89.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Steve Schonfeld opened a new position in Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt worth $30M.
- Steve Schonfeld's largest Q1 2020 buy was Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt: 3,000,000 shares worth $30M.
- Steve Schonfeld added most to Allergan plc in Q1 2020, an estimated $26.9M increase.
- Steve Schonfeld's biggest Q1 2020 reduction was Cheniere Energy, cutting an estimated $63.1M.
- Steve Schonfeld fully exited Vistra in Q1 2020, selling an estimated $89.7M.
- Steve Schonfeld's ten largest holdings make up 16% of its $1.59B portfolio in Q1 2020.
- Steve Schonfeld opened 455 new positions and closed 624 in Q1 2020.
- Steve Schonfeld's portfolio value fell 61% quarter-over-quarter to $1.59B.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2020, filed 15 May 2020.